ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Elderly"

  • Abstract Number: 1631 • 2015 ACR/ARHP Annual Meeting

    Adverse Events to Biologic Agents in Elderly Patients with Rheumatoid Arthritis: Cohort with 13 Years of Follow-up

    Zulema Rosales1,2, Leticia Leon1, Alejandro Gomez-Gomez2, Lucía Arietti2, Esperanza Pato Cour2, José Luis Fernández Rueda1, Juan A Jover2 and Lydia Abasolo1, 1Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain, 2Rheumatology, Hospital Clínico San Carlos, Madrid, Spain

    Background/Purpose: After more than a decade using biological agents (BA), is widely known their efficacy in the treatment of Rheumatoid Arthritis (RA) and their relationship…
  • Abstract Number: 1982 • 2015 ACR/ARHP Annual Meeting

    Sonographic Scoring of the Synovial Components in the Shoulder Revealed That Shoulder Synovitis in PMR Patients Is Milder Than That in Elderly-Onset RA Patients with PMR-like Onset

    Takeshi Suzuki, Division of Allergy and Rheumatology, Japanese Red Cross Medical Center, Tokyo, Japan; Division of Rheumatology, Mitsui Memorial Hosipital, Tokyo, Japan

    Background/Purpose: Through the clinical experience, we noted that there seems to be differences not in the kind or the frequency but in the severity of…
  • Abstract Number: 2759 • 2015 ACR/ARHP Annual Meeting

    Long-Term Survival of Biological Therapy in Rheumatoid Arthritis Elderly Patients in Clinical Practice

    Cristina Lajas1, Alejandro Gomez-Gomez1, Luis Rodriguez-Rodriguez2, Leticia Leon2, Cristina Vadillo1, Dalifer Freites Núñez1, Pilar Macarrón1, José María Leal Pozuelo2, Juan A Jover1 and Lydia Abasolo2, 1Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, 2Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain

    Background/Purpose: With the increasingly widespread use of biological agents (BA), a thorough knowledge of their long-term behavior in clinical practice is fundamental. The purpose of…
  • Abstract Number: 2764 • 2015 ACR/ARHP Annual Meeting

    Head-to-Head Comparison of the Retention Rate of First Biologics in Elderly Patients with Rheumatoid Arthritis in Japanese Clinical Practice: Results from the Multicenter Biologic Registry

    Masatoshi Hayashi1, Toshihisa Kanamono2, Hiroyuki Matsubara3, Toshihisa Kojima4, Koji Funahashi5, Nobunori Takahashi4 and Naoki Ishiguro6, 1Departments of Orthopedic surgery and Rheumatology, Nagano Red Cross Hospital, Nagano, Japan, 2Reumatology, Nagano Red Cross Hospital, Nagano, Japan, 3Department of Orthopedic Surgery and Rheumatology, Nagano Red Cross Hospital, Nagano, Japan, 4Department of Orthopedic Surgery, Nagoya University Hospital, Nagoya, Japan, 5Nagoya University, Nagoya, Japan, 6Department of Orthopedic Suregery, Nagoya University Hospital, Nagoya, Japan

    Background/Purpose: The objective of this report was to clarify and compare the retention rate of first biologics used to treat elderly Japanese patients with rheumatoid…
  • Abstract Number: 2765 • 2015 ACR/ARHP Annual Meeting

    Long-Term Retention Rate of First Biologics in Patients of Age over 75 Years with Rheumatoid Arthritis in Japanese Clinical Practice: Results from the Multicenter Biologic Registry

    Masatoshi Hayashi1, Toshihisa Kanamono2, Hiroyuki Matsubara3, Toshihisa Kojima4, Koji Funahashi5, Nobunori Takahashi4 and Naoki Ishiguro6, 1Department of Orhtopedic Surgery and Rheumatology, Nagano Red Cross Hospital, Nagano, Japan, 2Reumatology, Nagano Red Cross Hospital, Nagano, Japan, 3Department of Orthopedic Surgery and Rheumatology, Nagano Red Cross Hospital, Nagano, Japan, 4Department of Orthopedic Surgery, Nagoya University Hospital, Nagoya, Japan, 5Nagoya University, Nagoya, Japan, 6Department of Orthopedic Suregery, Nagoya University Hospital, Nagoya, Japan

    Background/Purpose: The objective of this report was to clarify and compare the retention rate of first biologics used to treat elderly Japanese patients with rheumatoid…
  • Abstract Number: 2909 • 2015 ACR/ARHP Annual Meeting

    A Systematic Review and Meta-Analysis of Cutaneous Manifestations in Late Versus Early-Onset Systemic Lupus Erythematosus

    Jennifer Medlin1, Karen E. Hansen2, Sara Fitz3 and Christie M. Bartels4, 1Internal Medicine, University of Wisconsin Hospitals and Clinics, Madison, WI, 2Rheumatology/Medicine, Univ of Wisconsin, Madison, WI, 3Department of Dermatology, Mercy Medical Center, Dubuque, IA, 4Medicine, Rheumatology, University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose:   Systemic lupus erythematosus (SLE) is commonly diagnosed in females of reproductive age, with those diagnosed after the age of 50 referred to as…
  • Abstract Number: 320 • 2015 ACR/ARHP Annual Meeting

    Effectiveness of Bracing in Elderly with Knee Osteoartritis: A Randomized Controlled Trial

    Christine Brumini Sr.1, Jamil Natour2, Lais Yumi Miura1 and Anamaria Martinez2, 1Rheumatology, University Federal of Sao Paulo, São Paulo, Brazil, 2Rheumatology Division, Federal University of Sao Paulo, Sao Paulo, Brazil

    Background/Purpose: Osteoarthritis (OA) is highly prevalent in the elderly, with the knee being the most commonly affected joint in this population. Knee braces are often…
  • Abstract Number: 497 • 2015 ACR/ARHP Annual Meeting

    Treatment Outcomes in Elderly Patients with Rheumatoid Arthritis: Results from a Nationwide Korean Biologics Registry

    Seung Min Jung1, Ji Yeon Lee1, Jung Hee Koh1, Seung-Ki Kwok2, Ji Hyeon Ju1, Chong-Hyeon Yoon1 and Sung-Hwan Park1, 1Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 2[email protected], Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease, predominantly affecting women in their fifth and sixth decades of life. Although population aging increases the…
  • Abstract Number: 857 • 2015 ACR/ARHP Annual Meeting

    Prognosis Value of Geriatric Assessment Scales in Older Adults with New Onset ANCA-­Associated Vasculitis: A Pilot Retrospective Study

    Antoine Néel1, Josephine Thomazeau1, Christelle Volteau2, Laure De Decker3, Christian Agard1, Marie Lino4, Julie Graveleau1, Fadi Fakhouri4 and Mohamed Hamidou1, 1Internal Medicine Department, Nantes University Hospital, Nantes, France, 2Clinical Research Department, Nantes University Hospital, Nantes, France, 3Department of Geriatrics, Nantes University Hospital, Nantes, France, 4Nephrology, Nantes University Hospital, Nantes, France

    Background/Purpose: 1/to assess the prognostic value of comorbidities, frailty and dependency as measures by dedicated geriatric scales, in older adults with ANCA-associated vasculitis (AAV). 2/…
  • Abstract Number: 894 • 2015 ACR/ARHP Annual Meeting

    Late-Onset IgA Vasculitis in Adult Patients Exhibits Distinct Clinical Characteristics and Outcomes

    Seokchan Hong1, Soo Min Ahn1, Doo-Ho Lim2, Byeongzu Ghang3, Wook Jang Seo4, Yong-Gil Kim1, Chang-Keun Lee1 and Bin Yoo2, 1Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Department of Rheumatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Univerisy of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 4Internal Medicine, Seoul Veterans Hospital, Seoul, South Korea

    Background/Purpose: To determine whether adult IgA vasculitis patients who developed disease at an older age differ from early-onset patients in terms of clinical features and…
  • Abstract Number: 1290 • 2015 ACR/ARHP Annual Meeting

    Burden of Rheumatoid Arthritis in the US Elderly Population: Comorbidities, Healthcare Resource Utilization, and Cost

    Chieh-I Chen1, Li Wang2, Wenhui Wei3, Huseyin Yuce4 and Kristine Phillips5, 1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 2Director, Analytic Research, STATinMED Research, Plano, TX, 3Sanofi-Aventis, Bridgewater, NJ, 4New York City College of Technology (CUNY), New York, NJ, 5Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Rheumatoid arthritis (RA) is a systemic inflammatory disease resulting in significant healthcare resource utilization (HRCU) and cost. Data on elderly RA patients are generally…
  • Abstract Number: 1325 • 2015 ACR/ARHP Annual Meeting

    Age Effects Joint Space Narrowing in Early Active Rheumatoid Arthritis Patients

    Xanthe M.E. Matthijssen1, Gülsah Akdemir1, Iris M. Markusse2, Yvonne P. Goekoop-Ruiterman3, K. Huub Han4, Annekoos L. Huidekoper5, Pit J.S.M. Kerstens6, Willem F. Lems7, T. W. J. Huizinga1 and Cornelia F. Allaart1, 1Rheumatology, LUMC, Leiden, Netherlands, 2LUMC, Leiden, Netherlands, 3Rheumatology, HAGA hospital, The Hague, Netherlands, 4Rheumatology, Maasstad hospital, Rotterdam, Netherlands, 5Rheumatology, Bronovo hospital, The Hague, Netherlands, 6Department of Rheumatology, Reade, Amsterdam, Netherlands, 7Rheumatology, Amsterdam Rheumatology and immunology Center, VU University medical center, Amsterdam, Netherlands

    Background/Purpose: Joint space narrowing (JSN) and erosions are the major radiologic markers of radiographic progression in rheumatoid arthritis (RA), as scored by the Sharp/van der…
  • Abstract Number: 1220 • 2014 ACR/ARHP Annual Meeting

    Higher Inflammatory Response in Elderly Patients during Gout Attack

    Ji Ae Yang1, Jae Hyun Lee1, Eun Young Lee2, Eun Bong Lee1, Yeong Wook Song3 and Jin Kyun Park1, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 2Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea

    Higher inflammatory response in elderly patients during gout attack Background/Purpose Clinical experiences suggest that gout attacks in elderly patients are accompanied by stronger systemic inflammatory…
  • Abstract Number: 1109 • 2014 ACR/ARHP Annual Meeting

    Impact of Age on Symptom Severity and Disease Management at Fibromyalgia Diagnosis

    Emmanouil Rampakakis1, Mary-Ann Fitzcharles2, Peter A. Ste-Marie3, John S. Sampalis1 and Yoram Shir3, 1JSS Medical Research, Montreal, QC, Canada, 2Rheumatology and Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 3Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Population studies indicate that older persons experience more pain generally. Fibromyalgia (FM) affects persons of all ages, with previous studies on the impact of…
  • Abstract Number: 1064 • 2014 ACR/ARHP Annual Meeting

    Unique Profile of Cardiovascular Risk Factors in Rheumatoid Arthritis High-Risk Populations with Insufficient Risk Control

    Ulf Müller-Ladner1, Stefan Kleinert2, Klaus Krüger3, Bianca Wittig4 and Rolf Hecker4, 1Rheumatologie und klinische Immunologie, Kerckhoff-Klinik GmbH, Abt. Rheumatologie und klinische Immunologie, Bad Nauheim, Germany, 2Rheumatologie, Praxisgemeinschaft Rheumatologie-Nephrologie, Rheumatologische Schwerpunktpraxis, Erlangen, Germany, 3Praxiszentrum St. Bonifatius, München, Germany, 4Abbvie Deutschland GmbH & Co. KG, Wiesbaden, Germany

    Background/Purpose More than 50% of premature deaths in patients with rheumatoid arthritis (RA) are due to cardiovascular disease (CVD). Both the cumulative burden of inflammation…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology